Biocon Biologics marks one year as global biosimilars enterprise
Biocon’s subsidiary, Biocon Biologics Limited (BBL), has announced the completion of its first year as a fully integrated ...
Hosted on MSN22m
FDA accepts Sentynl’s Menkes disease therapy NDA for priority review
Sentynl took over the therapy’s development and commercialisation from Fortress Biotech's subsidiary Cyprium Therapeutics.
BioPharma Dive26m
ALS drugs from Denali, Calico come up short, marking setback for Healey trial
Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...
Scripps News on MSN28m
FDA calling on pulse oximeter makers to make life-saving changes to devices
Pulse oximeters help doctors evaluate a person's pulse rate and the oxygen saturation of your blood. The FDA is proposing ...
FDA limits toxic lead in some baby foods
The U.S. Food and Drug Administration on Monday set maximum levels for lead in baby foods like jarred fruits and vegetables, ...
Florida grand jury investigating COVID-19 vaccines finds no evidence of criminal activity
A statewide grand jury convened at the request of Florida Gov. Ron DeSantis has found no evidence of criminal activity ...
JD Supra59m
FDA Approves Celltrion’s STEQEYMA (ustekinumab-stba)
According to Celltrion, STEQEYMA is expected to be marketed in the United States beginning in February 2025. DISCLAIMER: Because of the generality of this update, the information provided herein may ...
FDA revises limit on lead in some baby food; Here’s what to know
The US FDA has issued guidance to limit lead levels in processed baby foods, aiming to reduce exposure by 20%-30%.